2026-2027 Objectives

  • Produce OKnets through our WHO-approved factory in Tanzania
  • Conduct randomized field trials under WHO-approved supervision
  • We target a 60–80% improvement in adoption and hang rates
  • Obtain WHO regulatory approval, unlocking procurement by national malaria programs 
  • Scale manufacturing and deployment
  • Save more lives for every malaria-prevention dollar spent
OKnet Objectives